Click HERE to download the PDF version

Guangzhou RiboBio Co., Ltd. (RiboBio), founded in 2004, is a leading nucleic acids-based biotech company in China with over 240 employees and 6,500 sq meter space accommodating the cutting-edge facilities. RiboBio is currently led by a Nobel Laureate as well as distinguished experts in the field of nucleic acids. RiboBio, which holds the world-class R&D team and the leading technologies in RNA-based products and services, develops and supplies various oligonucleotides, RNAi, miRNA, mRNA, and lncRNA products, as well as providing the oligonucleotide-based drug discovery & development services. In 2013, RiboBio built the first GMP oligonucleotide manufacturing facility in China and was issued the Oligonucleotide API Drug Manufacturing Permit by CFDA in June, 2016. RiboBio established an oligonucleotide manufacturin ...